Holbrook Anne, Thabane Lehana, Keshavjee Karim, Dolovich Lisa, Bernstein Bob, Chan David, Troyan Sue, Foster Gary, Gerstein Hertzel
Division of Clinical Pharmacology and Therapeutics, McMaster University, Hamilton ON
CMAJ. 2009 Jul 7;181(1-2):37-44. doi: 10.1503/cmaj.081272.
Diabetes mellitus is a complex disease with serious complications. Electronic decision support, providing information that is shared and discussed by both patient and physician, encourages timely interventions and may improve the management of this chronic disease. However, it has rarely been tested in community-based primary care.
In this pragmatic randomized trial, we randomly assigned adult primary care patients with type 2 diabetes to receive the intervention or usual care. The intervention involved shared access by the primary care provider and the patient to a Web-based, colour-coded diabetes tracker, which provided sequential monitoring values for 13 diabetes risk factors, their respective targets and brief, prioritized messages of advice. The primary outcome measure was a process composite score. Secondary outcomes included clinical composite scores, quality of life, continuity of care and usability. The outcome assessors were blinded to each patient's intervention status.
We recruited sequentially 46 primary care providers and then 511 of their patients (mean age 60.7 [standard deviation 12.5] years). Mean follow-up was 5.9 months. The process composite score was significantly better for patients in the intervention group than for control patients (difference 1.27, 95% confidence interval [CI] 0.79-1.75, p < 0.001); 61.7% (156/253) of patients in the intervention group, compared with 42.6% (110/258) of control patients, showed improvement (difference 19.1%, p < 0.001). The clinical composite score also had significantly more variables with improvement for the intervention group (0.59, 95% CI 0.09-1.10, p = 0.02), including significantly greater declines in blood pressure (-3.95 mm Hg systolic and -2.38 mm Hg diastolic) and glycated hemoglobin (-0.2%). Patients in the intervention group reported greater satisfaction with their diabetes care.
A shared electronic decision-support system to support the primary care of diabetes improved the process of care and some clinical markers of the quality of diabetes care. (ClinicalTrials.gov trial register no. NCT00813085.).
糖尿病是一种伴有严重并发症的复杂疾病。电子决策支持系统可提供患者和医生共同分享及讨论的信息,有助于及时干预,并可能改善这种慢性病的管理。然而,其在社区基层医疗中的应用鲜有测试。
在这项实用随机试验中,我们将成年2型糖尿病基层医疗患者随机分为接受干预组或常规治疗组。干预措施包括基层医疗服务提供者和患者共同使用一个基于网络的、带有颜色编码的糖尿病追踪器,该追踪器可提供13项糖尿病风险因素的连续监测值、各自的目标值以及简短且按优先级排列的建议信息。主要结局指标是一个过程综合评分。次要结局指标包括临床综合评分、生活质量、医疗连续性和易用性。结局评估者对每位患者的干预状态不知情。
我们先后招募了46名基层医疗服务提供者及其511名患者(平均年龄60.7岁[标准差12.5岁])。平均随访时间为5.9个月。干预组患者的过程综合评分显著优于对照组患者(差值为1.27,95%置信区间[CI]为0.79 - 1.75,p < 0.001);干预组61.7%(156/253)的患者病情有所改善,而对照组为42.6%(110/258)(差值为19.1%,p < 0.001)。干预组临床综合评分中改善的变量也显著更多(0.59,95%CI为0.09 - 1.10,p = 0.02),包括收缩压(-3.95 mmHg)和舒张压(-2.38 mmHg)以及糖化血红蛋白(-0.2%)的显著下降。干预组患者对糖尿病护理更为满意。
一个支持糖尿病基层医疗的共享电子决策支持系统改善了护理过程以及糖尿病护理质量的一些临床指标。(ClinicalTrials.gov试验注册号:NCT00813085.)